148 related articles for article (PubMed ID: 10824992)
1. Modular retro-vectors for transgenic and therapeutic use.
Solaiman F; Zink MA; Xu G; Grunkemeyer J; Cosgrove D; Saenz J; Hodgson CP
Mol Reprod Dev; 2000 Jun; 56(2 Suppl):309-15. PubMed ID: 10824992
[TBL] [Abstract][Full Text] [Related]
2. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4511-8. PubMed ID: 17671137
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a semi-replicative gene delivery system allowing propagation of complementary defective retroviral vectors.
Trajcevski S; Solly SK; Frisén C; Trenado A; Cosset FL; Klatzmann D
J Gene Med; 2005 Mar; 7(3):276-87. PubMed ID: 15515136
[TBL] [Abstract][Full Text] [Related]
4. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
5. Construction of a retroviral vector production system with the minimum possibility of a homologous recombination.
Yu SS; Han E; Hong Y; Lee JT; Kim S; Kim S
Gene Ther; 2003 Apr; 10(8):706-11. PubMed ID: 12692599
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.
Sinn PL; Sauter SL; McCray PB
Gene Ther; 2005 Jul; 12(14):1089-98. PubMed ID: 16003340
[TBL] [Abstract][Full Text] [Related]
7. Design of retroviral vectors and helper cells for gene therapy.
Hu WS; Pathak VK
Pharmacol Rev; 2000 Dec; 52(4):493-511. PubMed ID: 11121508
[TBL] [Abstract][Full Text] [Related]
8. Towards efficient cell targeting by recombinant retroviruses.
Marin M; Noël D; Piechaczyk M
Mol Med Today; 1997 Sep; 3(9):396-403. PubMed ID: 9302690
[TBL] [Abstract][Full Text] [Related]
9. Rhesus monkey model for fetal gene transfer: studies with retroviral- based vector systems.
Tarantal AF; O'Rourke JP; Case SS; Newbound GC; Li J; Lee CI; Baskin CR; Kohn DB; Bunnell BA
Mol Ther; 2001 Feb; 3(2):128-38. PubMed ID: 11237669
[TBL] [Abstract][Full Text] [Related]
10. [Construction of three transgenic vectors carrying the latent membrane protein gene of Epstein-Barr virus].
Xiao Z; Guan Y; Duan C; Chen Z; Yao K
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(1):1-4. PubMed ID: 11938726
[TBL] [Abstract][Full Text] [Related]
11. High expression of transgenes mediated by hybrid retroviral vectors in hepatocytes: comparison of promoters from murine retroviruses in vitro and in vivo.
Ohnishi N; Itoh K; Itoh Y; Baum C; Higashitsuji H; Yamaguchi K; Tsuji T; Okanoue T; Fujita J
Gene Ther; 2002 Feb; 9(4):303-6. PubMed ID: 11896470
[TBL] [Abstract][Full Text] [Related]
12. Replicating retroviral vectors mediating continuous production and secretion of therapeutic gene products from cancer cells.
Finger C; Sun Y; Sanz L; Alvarez-Vallina L; Buchholz CJ; Cichutek K
Cancer Gene Ther; 2005 May; 12(5):464-74. PubMed ID: 15692609
[TBL] [Abstract][Full Text] [Related]
13. Reticuloendotheliosis viruses and derived vectors.
Dornburg R
Gene Ther; 1995 Jul; 2(5):301-10. PubMed ID: 7671105
[TBL] [Abstract][Full Text] [Related]
14. Progress toward the genetic treatment of the beta-thalassemias.
Sadelain M; Lisowski L; Samakoglu S; Rivella S; May C; Riviere I
Ann N Y Acad Sci; 2005; 1054():78-91. PubMed ID: 16339654
[TBL] [Abstract][Full Text] [Related]
15. Retroviral vector-mediated gene expression in hematopoietic cells.
Baum C; Richters A; Ostertag W
Curr Opin Mol Ther; 1999 Oct; 1(5):605-12. PubMed ID: 11249667
[TBL] [Abstract][Full Text] [Related]
16. Retroviral vectors for the transduction of autoregulated, bidirectional expression cassettes.
Unsinger J; Kröger A; Hauser H; Wirth D
Mol Ther; 2001 Nov; 4(5):484-9. PubMed ID: 11708885
[TBL] [Abstract][Full Text] [Related]
17. General principles of retrovirus vector design.
Chang T; Yee JK
Methods Enzymol; 2012; 507():1-14. PubMed ID: 22365766
[TBL] [Abstract][Full Text] [Related]
18. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer.
Blesch A
Methods; 2004 Jun; 33(2):164-72. PubMed ID: 15121171
[TBL] [Abstract][Full Text] [Related]
19. Intraarterial delivery of genetic vectors for the treatment of malignant brain tumors.
Cohen ZR; Duvdevani R; Nass D; Hadani M; Ram Z
Isr Med Assoc J; 2001 Feb; 3(2):117-20. PubMed ID: 11344821
[TBL] [Abstract][Full Text] [Related]
20. B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory element.
Werner M; Kraunus J; Baum C; Brocker T
Gene Ther; 2004 Jun; 11(12):992-1000. PubMed ID: 15029232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
